+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Motion Sickness Treatment Market - Global Forecast 2026-2032- Product Image
Motion Sickness Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Motion Sickness Treatment Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055743
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Motion Sickness Treatment Market is projected to reach USD 865.63 Million in 2026. It is expected to continue growing at a CAGR of 8.77%, reaching USD 1.43 Billion by 2032.

Motion Sickness Treatment: Executive Summary

Motion sickness treatment addresses nausea, vomiting, dizziness, and related discomfort triggered by travel or visual-vestibular conflict. The treatment landscape includes preventive medicines, symptom-relief products, behavioral measures, and emerging digital or device-enabled approaches. Demand is shaped by travel activity, patient awareness, access to healthcare, regulatory requirements, and preferences for non-sedating options.

Treatment Shifts Toward Prevention, Convenience, and Lower Sedation

The landscape is shifting from treatment after symptoms begin toward prevention before exposure, supported by clearer patient education and broader use of transdermal, oral, and non-pharmacological approaches. Convenience is increasingly important for travelers, while sedation, dry mouth, blurred vision, and other adverse effects remain central considerations. Clinical guidance continues to emphasize matching treatment choice to trip duration, age, health status, and exposure type.

Artificial Intelligence Improves Personalization and Care Delivery

Artificial intelligence can support motion sickness management by identifying symptom patterns, analyzing links between movement and physiological responses, and helping tailor preventive guidance. It may also improve digital triage, adherence reminders, and educational content. However, reliable clinical validation, transparent data governance, protection of sensitive health information, and appropriate clinician oversight are necessary before AI-generated recommendations can be used safely in routine care.

Regional Differences Reflect Travel Patterns, Access, and Regulation

North America combines strong consumer awareness with broad access to prescription and over-the-counter options. Latin America shows varied availability and affordability across healthcare systems. Europe is influenced by coordinated regulatory standards and demand for evidence-based, convenient products. The Middle East is shaped by international travel, pilgrimage-related journeys, and differing access across countries. Africa has substantial variation in distribution, diagnosis, and affordability. Asia-Pacific combines major travel populations, diverse regulatory environments, and growing interest in preventive care and digital health tools.

Economic and Institutional Groups Shape Access and Standards

ASEAN markets reflect diverse healthcare systems, tourism flows, and regulatory pathways, creating opportunities for adaptable education and distribution. BRICS countries span large and varied populations, with access influenced by domestic manufacturing, public healthcare capacity, and income differences. The European Union benefits from regulatory coordination while retaining national differences in reimbursement and clinical practice. G7 countries generally have mature healthcare infrastructure and strong expectations for safety and convenience. GCC markets are influenced by high international mobility and concentrated healthcare investment. NATO members represent a broad set of health systems where travel medicine readiness and operational mobility can affect treatment access.

Country Contexts Reveal Distinct Treatment Priorities

Australia emphasizes travel health, consumer self-care, and access across geographically dispersed communities. Brazil and Mexico require approaches sensitive to regional healthcare differences and affordability. Canada and the United States combine established clinical resources with demand for convenient non-sedating choices. China and India present large, diverse populations and differing access between urban and rural settings. France, Germany, Italy, Spain, and the United Kingdom operate within mature European healthcare environments, with national variation in guidance, pharmacy practice, and reimbursement. Japan and South Korea show strong consumer interest in preventive health, product quality, and technology-enabled support. Russia presents distinctive regulatory and distribution considerations alongside varied regional access.

Industry Leaders Should Prioritize Safe, Accessible, and Evidence-Based Solutions

Leaders should develop clear prevention-first education that explains appropriate use, contraindications, sedation risks, and when medical advice is needed. Product portfolios should address different trip durations and user preferences while improving ease of administration. Partnerships with pharmacies, travel clinics, transport operators, and digital health services can strengthen distribution and adherence. Organizations should also invest in post-market safety monitoring, region-specific regulatory expertise, inclusive clinical evidence, and AI governance frameworks that keep clinicians and users informed about limitations.

Methodology: Structured Review of Treatment, Access, and Innovation Factors

This executive summary uses a qualitative framework focused on motion sickness symptoms, preventive and symptomatic treatment approaches, patient and travel behavior, healthcare access, regulatory context, and technology adoption. Regional, group, and country observations are synthesized from established public-health and clinical considerations rather than numerical market projections. The analysis distinguishes current practice patterns from emerging opportunities and avoids unsupported estimates, market shares, or forecasts.

Conclusion: Prevention and Personalization Define the Next Phase

Motion sickness treatment is evolving toward earlier intervention, greater convenience, and more individualized support. Differences in travel behavior, healthcare access, regulation, and consumer expectations will continue to shape adoption across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The strongest strategies will combine clinically responsible products, practical education, equitable distribution, and carefully governed digital tools.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Motion Sickness Treatment Market, by Type Of Drugs
7.1. Introduction
7.2. Anticholinergics
7.3. Antihistamines
8. Motion Sickness Treatment Market, by Treatment Type
8.1. Introduction
8.2. Natural Remedies
8.3. Over-the-Counter Medications
8.4. Prescription Medications
9. Motion Sickness Treatment Market, by Dosage Forms
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Transdermal Patches
10. Motion Sickness Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Online Pharmacies
10.3. Retail Pharmacies
11. Motion Sickness Treatment Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Motion Sickness Treatment Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Motion Sickness Treatment Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Motion Sickness Treatment Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Amneal Pharmaceuticals LLC
16.2. Astellas Pharma Inc.
16.3. Baxter International Inc.,
16.4. Bayer AG
16.5. BONINE by Wellspring Pharmaceutical Corporation
16.6. Cipla Limited
16.7. CVS Health Corporation
16.8. GlaxoSmithKline plc
16.9. Lupin Limited
16.10. Myungmoon Pharma Co. Ltd.
16.11. Novartis AG
16.12. Perrigo Company PLC
16.13. Pfizer Inc.
16.14. Prestige Consumer Healthcare Inc.,
16.15. Reliefband Technologies LLC
16.16. Sanofi S.A.
16.17. Taj Pharmaceuticals Limited
16.18. Teva Pharmaceutical Industries Limited
16.19. Torrent Pharmaceuticals Ltd
16.20. WellSpring Pharmaceutical Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Motion Sickness Treatment Market, Years Considered for the Study
FIGURE 2. Global Motion Sickness Treatment Market, Research Design
FIGURE 3. Global Motion Sickness Treatment Market, Research Framework
FIGURE 4. Global Motion Sickness Treatment Market, Data Triangulation
FIGURE 5. Global Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Motion Sickness Treatment Market Size, by Type Of Drugs, 2025 vs 2032 (%)
FIGURE 7. Global Motion Sickness Treatment Market Size, by Type Of Drugs, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Motion Sickness Treatment Market Size, by Treatment Type, 2025 vs 2032 (%)
FIGURE 9. Global Motion Sickness Treatment Market Size, by Treatment Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Motion Sickness Treatment Market Size, by Dosage Forms, 2025 vs 2032 (%)
FIGURE 11. Global Motion Sickness Treatment Market Size, by Dosage Forms, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Motion Sickness Treatment Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 13. Global Motion Sickness Treatment Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Motion Sickness Treatment Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Motion Sickness Treatment Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Motion Sickness Treatment Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Motion Sickness Treatment Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Motion Sickness Treatment Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Motion Sickness Treatment Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Motion Sickness Treatment Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Motion Sickness Treatment Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Motion Sickness Treatment Market Segmentation & Coverage
TABLE 2. Global Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 3. Global Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 4. Global Anticholinergics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anticholinergics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anticholinergics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 11. Global Natural Remedies Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Natural Remedies Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Natural Remedies Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Over-the-Counter Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Over-the-Counter Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Over-the-Counter Medications Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Prescription Medications Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Prescription Medications Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Prescription Medications Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 21. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 26. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 27. Global Transdermal Patches Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Transdermal Patches Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Transdermal Patches Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 31. Global Online Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Online Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Online Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 38. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Home Care Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Home Care Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Home Care Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 54. North America Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. North America Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 56. North America Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 57. North America Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 58. North America Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 59. North America Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 60. Latin America Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Latin America Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 62. Latin America Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 63. Latin America Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 64. Latin America Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 65. Latin America Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. Europe Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Europe Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 68. Europe Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 69. Europe Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 70. Europe Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 71. Europe Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 72. Middle East Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Middle East Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 74. Middle East Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 75. Middle East Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 76. Middle East Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 77. Middle East Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 78. Africa Motion Sickness Treatment Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Africa Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 80. Africa Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 81. Africa Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 82. Africa Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 83. Africa Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Global Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. ASEAN Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. ASEAN Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 87. ASEAN Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 88. ASEAN Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 89. ASEAN Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 90. ASEAN Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 91. GCC Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. GCC Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 93. GCC Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 94. GCC Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 95. GCC Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 96. GCC Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 97. European Union Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. European Union Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 99. European Union Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 100. European Union Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 101. European Union Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 102. European Union Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 103. BRICS Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. BRICS Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 105. BRICS Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 106. BRICS Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 107. BRICS Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 108. BRICS Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. G7 Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. G7 Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 111. G7 Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 112. G7 Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 113. G7 Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. G7 Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 115. NATO Motion Sickness Treatment Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 117. NATO Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 118. NATO Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 119. NATO Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 120. NATO Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 121. Global Motion Sickness Treatment Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. United States Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 123. United States Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 124. United States Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 125. United States Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 126. United States Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 127. United States Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 128. Canada Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 129. Canada Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 130. Canada Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 131. Canada Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 132. Canada Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 133. Canada Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Mexico Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 135. Mexico Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 136. Mexico Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 137. Mexico Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 138. Mexico Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 139. Mexico Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 140. Brazil Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 141. Brazil Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 142. Brazil Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 143. Brazil Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 144. Brazil Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. Brazil Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 146. United Kingdom Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 147. United Kingdom Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 148. United Kingdom Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 149. United Kingdom Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 150. United Kingdom Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 151. United Kingdom Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Germany Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 153. Germany Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 154. Germany Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 155. Germany Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 156. Germany Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. Germany Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. France Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 159. France Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 160. France Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 161. France Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 162. France Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 163. France Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. Russia Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 165. Russia Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 166. Russia Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 167. Russia Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 168. Russia Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 169. Russia Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Italy Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 171. Italy Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 172. Italy Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 173. Italy Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 174. Italy Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 175. Italy Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 176. Spain Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 177. Spain Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 178. Spain Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 179. Spain Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 180. Spain Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 181. Spain Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. China Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 183. China Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 184. China Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 185. China Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 186. China Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 187. China Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. India Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 189. India Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 190. India Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 191. India Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 192. India Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. India Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Japan Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 195. Japan Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 196. Japan Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 197. Japan Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 198. Japan Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 199. Japan Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Australia Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 201. Australia Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 202. Australia Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 203. Australia Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 204. Australia Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 205. Australia Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. South Korea Motion Sickness Treatment Market Size, 2017-2032 (USD Million)
TABLE 207. South Korea Motion Sickness Treatment Market Size, by Type Of Drugs, 2017-2032 (USD Million)
TABLE 208. South Korea Motion Sickness Treatment Market Size, by Treatment Type, 2017-2032 (USD Million)
TABLE 209. South Korea Motion Sickness Treatment Market Size, by Dosage Forms, 2017-2032 (USD Million)
TABLE 210. South Korea Motion Sickness Treatment Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 211. South Korea Motion Sickness Treatment Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. Global Motion Sickness Treatment Market Share, by Key Player, 2025
TABLE 213. Global Motion Sickness Treatment Market, Key Experts

Companies Mentioned

  • Amneal Pharmaceuticals LLC
  • Astellas Pharma Inc.
  • Baxter International Inc.,
  • Bayer AG
  • BONINE by Wellspring Pharmaceutical Corporation
  • Cipla Limited
  • CVS Health Corporation
  • GlaxoSmithKline plc
  • Lupin Limited
  • Myungmoon Pharma Co. Ltd.
  • Novartis AG
  • Perrigo Company PLC
  • Pfizer Inc.
  • Prestige Consumer Healthcare Inc.,
  • Reliefband Technologies LLC
  • Sanofi S.A.
  • Taj Pharmaceuticals Limited
  • Teva Pharmaceutical Industries Limited
  • Torrent Pharmaceuticals Ltd
  • WellSpring Pharmaceutical Corporation

Related Topics

Related Reports

Motion Sickness Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type, Distribution Channel, Dosage Form - Product Image

Motion Sickness Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type, Distribution Channel, Dosage Form

  • Report
  • 160 Pages
  • Global
From
Motion Sickness Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Motion Sickness Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Motion Sickness Drugs - Global Strategic Business Report - Product Image

Motion Sickness Drugs - Global Strategic Business Report

  • Report
  • 270 Pages
  • Global
From
Motion Sickness Treatment - Global Strategic Business Report - Product Image

Motion Sickness Treatment - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Wearable Anti-Motion Sickness Bracelet Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Wearable Anti-Motion Sickness Bracelet Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Motion Sickness Drug Market

The Motion Sickness Drug market is a subset of the Over the Counter (OTC) Drug market. These drugs are used to treat the symptoms of motion sickness, such as nausea, dizziness, and vomiting. Common ingredients in these drugs include dimenhydrinate, meclizine, and scopolamine. These drugs are available in a variety of forms, including tablets, capsules, and patches. They are often used to prevent motion sickness before it occurs, as well as to treat it once it has started. Some of the companies in the Motion Sickness Drug market include Johnson & Johnson, GlaxoSmithKline, Bayer, Pfizer, and Novartis. These companies produce a variety of motion sickness drugs, including Dramamine, Bonine, and Transderm Scop. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.